Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound (Q39270649)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 9, 1979

Language	Label	Description	Also known as
English	Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound	scientific article published on April 9, 1979

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound (English)

reason for preferred rank

most precise value

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Decreased antistereotypic effect of neuroliptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

author name string

Scheel-Krüger J

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A. V. Christensen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

J. Arnt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

J. Scheel-Krüger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A39205

2 November 2022

language of work or name

0 references

publication date

1 April 1979

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

9 April 1979

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=39205

2 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0024320579900109?httpAccept=text/xml

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

https://api.elsevier.com/content/article/PII:0024320579900109?httpAccept=text/plain

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1395-1402

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Rotational behavior induced in rats by intranigral picrotoxin

1

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Antagonism of Methylphenidate-Induced Stereotyped Gnawing in Mice

3

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Central Effects of Anticholinergic Drugs Measured by the Apomorphine Gnawing Test in Mice

4

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain

6

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice

7

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: A complex GABA-dopamine interaction

8

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra.

9

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral gabaergic pathway

10

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonists

11

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Rotational behaviour after unilateral intranigral injection of muscimol in rats

12

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

GABA-like properties of flurazepam and baclofen suggested by rotational behaviour following unilateral intranigral injection: a comparison with the GABA agonist muscimol [proceedings]

13

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

A new class of GABA agonist

15

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons

18

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Heparin stability in dextrose solutions [proceedings]

20

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Central GABA receptor agonists: Comparison of muscimol and baclofen

21

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

GABA receptor binding with 3H (+) bicuculline–methiodide in rat CNS

22

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Peripheral and central muscarinic receptor affinity of psychotropic drugs

24

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

25

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain

26

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Inhibition by Neuroleptics of Uptake of 3H-GABA into Rat Brain Synaptosomes

27

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

29

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol antagonizes morphine hypermotility without potentiation of analgesia

30

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

31

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Muscimol: GABA agonist therapy in schizophrenia

34

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Drug Therapy of Tardive Dyskinesia

35

1 reference

10.1016/0024-3205(79)90010-9

https://api.crossref.org/works/10.1016/0024-3205(79)90010-9

2 November 2022

Identifiers

10.1016/0024-3205(79)90010-9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39270649&oldid=1763120799"